Absolutely. All OPT have to do is increase the sample size and these results will reach statistical significance.
Let's not forget how well OPT did to show these results to the market just before COVID caused a major disruption to clinic visits.
Seriously. Results like the ones they reported yesterday don't happen by accident, or as a statistical anomaly. If they give another 100 patients a monthly injection for 3 months, I reckon that's all that would be required to achieve statistical significance.
If you have a look at the clinical trial on clinicaltrials.org, it looks like the study is set to be finalised in August 2020.
PS: if you're not an ophthalmologist, you're doing well. You have a solid understanding of this trial
Absolutely. All OPT have to do is increase the sample size and...
Add OPT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
61.0¢ |
Change
-0.010(1.61%) |
Mkt cap ! $404.3M | |||
| Open | High | Low | Value | Volume |
| 62.5¢ | 62.5¢ | 60.5¢ | $208.1K | 341.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2890 | 61.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 62.0¢ | 3370 | 1 |
View Market Depth
| Last trade - 16.10pm 02/05/2024 (20 minute delay) ? |
|
|||||
|
Last
61.5¢ |
Change
-0.010 ( 0.69 %) |
||||
| Open | High | Low | Volume | ||
| 62.0¢ | 62.0¢ | 60.5¢ | 17553 | ||
| Last updated 15.59pm 02/05/2024 ? | |||||
| OPT (ASX) Chart |